Tirzepatide is also available as a once-weekly injection
Zepbound, which contains the active ingredient tirzepatide, has Food and Drug Administration (FDA) approval for the following: weight management in adults with obesity weight management in adults with overweight who have at least one weight-related condition obstructive sleep apnea (OSA) in adults with obesity Whether your insurance will cover Zepbound will depend on several factors, including your specific plan and whether you meet certain prescribing criteria
You required medical intervention as a result of using the drug, such as hospitalization, emergency room visits, or a consultation with a gastroenterologist, ophthalmologist, or other medical professional
However, they have slightly different uses
This page lives in the PlexusDx Education Hub, where we unpack GLP-1 science, delivery formats, and the genetic factors behind metabolic response